Biocon Stock

Biocon EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Biocon (BIOCON.NS) as of Jul 24, 2026 is 41.85. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 34.71 — a change of 20.56% (higher).

EV/EBIT

41.85

YoY

20.56%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Biocon is 2026 41.85 . EV/EBIT (Enterprise Value to EBIT) of Biocon was 2025 34.71 . It decreases by 20.56% higher compared to the previous year.

The Biocon EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
36.96 base
Jan 1, 2020
52.46 base
Jan 1, 2021
46.06 base
Jan 1, 2022
26.42 base
Jan 1, 2023
18.36 base
Jan 1, 2024
24.52 base
Jan 1, 2025
31.89 base
Jan 1, 2026 (e)
32.11 base
YEARPRICE-TO-EBIT
2026 est 32.11
2025 31.89
2024 24.52
2023 18.36
2022 26.42
2021 46.06
2020 52.46
2019 36.96
2018 84.13
2017 45.36
2016 35.18
2015 20.41
2014 16.24
2013 23.03
2012 16.55
2011 14.65
2010 24.36
2009 24.42
2008 11.27
2007 25.02
2006 18.03
Access this data via the Eulerpool API
Get Free API Key

Biocon Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Biocon's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Biocon's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Biocon's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Biocon grows earnings faster than its peers.

Biocon Stock analysis

What does Biocon do? Biocon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biocon stock

EV/EBIT (Enterprise Value to EBIT) of Biocon is 41.85 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Biocon

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Biocon